Trinity Biotech | TRIB - Gross Profit On Sales

Stock Price
0.61
Daily Change
0.005 0.79%
Monthly
-13.12%
Yearly
7.88%
Q2 Forecast
0.58

Trinity Biotech reported $6.47M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
EDAP TMS EUR 5.97M 850K Sep/2025
J&J USD 16.6B 118M Dec/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
OraSure Technologies USD 11.34M 435K Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Siemens EUR 8.1B 567M Sep/2025
Surmodics USD 20.08M 31.62M Jun/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Tosoh JPY 67.57B 10.89B Sep/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025
Veracyte USD 101.97M 10.69M Dec/2025